<DOC>
	<DOC>NCT00457470</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of AG-014699 in diabetic patients</brief_summary>
	<brief_title>A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Rucaparib</mesh_term>
	<criteria>diabetic patients, either man or woman, with diabetic retinopathy, at least 18 years of age patients treated with laser therapy within the last 90 days patients with likelyhood to require cataract surgery within 3 months Uncontrolled diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>